Vascular Malformation
12
2
3
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.3%
1 terminated out of 12 trials
83.3%
-3.3% vs benchmark
17%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (12)
AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study
MiDura-Study (Neuro-Patch in Duraplasty)
Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
Comparative Study Between Sclerosing Agents Used in Treatment of Vascular Malformation
suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
Diagnostic Imaging of Vascular Malformations Using MSOT and ULM
A Study of Enalapril in Treatment of Venous Malformations
A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology
Bioseal Dural Sealing Study BIOS-14-001
Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding